Association of metabolic syndrome with various anthropometric and atherogenic parameters in the Kazakh population in China.
BACKGROUND
This study aimed to evaluate the association of the metabolic syndrome (MetS) with various anthropometric and atherogenic parameters in adult Kazakh population in China.


METHODS
Four thousand ninety-four Kazakhs were recruited since 2007 to 2010. MetS and its components were confirmed according to IDF criteria. Area under the curve (AUC) of each variable was compared. Sensitivity (Sen), specificity (Spe), shortest distance in receiver's operating characteristic curve (ROC) and cutoff of each variable to diagnose MetS were calculated.


RESULTS
28.6 % of men and 31.0 % of women had MetS in the Kazakh population. In men, WHtR had the highest AUC value 0.821, followed by BMI (0.801), TG/HDL-C (0.792), WHR (0.776) and BAI (0.666). In women, WHtR also had the highest AUC value (0.835), following by BMI (0.789), WHR (0.778), TG/HDL-C (0.778) and BAI (0.751). WHtR had the shortest ROC distance that was 0.37 and the optimal cutoff was 0.55 in men. In women, WHtR also had the shortest ROC distance of 0.35 and the optimal cutoff was 0.54.


CONCLUSIONS
WHtR is the best predictor of MetS in both Kazakh men and women according to the IDF criteria.
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Xiaocui
X
Chen
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China.
Chunhui
C
He
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China. myt-xj@163.com.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China. myt-xj@163.com.
Yitong
Y
Ma
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China.
Yining
Y
Yang
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Fen
F
Liu
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China.
Xiang
X
Ma
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China.
Xiaomei
X
Li
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.|Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137 South Liyushan Road, Urumqi, 830054, People's Republic of China.
Xiang
X
Xie
Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China. chenbangdang@126.com.
Bangdang
B
Chen
Body adiposity index; Body mass index; Metabolic syndrome; TG/HDL-C; Waist to height ratio; Waist to hip ratio
Eur J Clin Nutr. 2015 Aug;69(8):954-60
25782420
Obesity (Silver Spring). 2011 May;19(5):1083-9
21372804
PLoS One. 2011;6(6):e20259
21697988
Am J Hypertens. 1992 Apr;5(4 Pt 1):207-9
1599634
J Endocrinol Invest. 2006 Dec;29(11):989-96
17259796
Obes Rev. 2012 Dec;13 Suppl 2:6-13
23107255
PLoS One. 2012;7(5):e36936
22590636
PLoS One. 2013 Nov 07;8(11):e80185
24244645
Environ Health Prev Med. 2011 Jan;16(1):52-60
21432217
Med Clin North Am. 2011 Sep;95(5):919-37
21855700
Am J Clin Nutr. 2004 Nov;80(5):1129-36
15531658
Lancet. 2005 Apr 16-22;365(9468):1398-405
15836888
Ann Nutr Metab. 2014;65(4):280-8
25376983
Lancet. 2005 Sep 24-30;366(9491):1059-62
16182882
J Epidemiol. 2012;22(5):433-9
22955044
BMC Public Health. 2012 Jan 21;12:64
22264227
PLoS One. 2013 Sep 09;8(9):e74121
24040183
Metab Syndr Relat Disord. 2006 Spring;4(1):28-34
18370767
Diabetes Care. 2007 Mar;30(3):701-6
17327344
J Diabetes Complications. 2007 Sep-Oct;21(5):315-9
17825756
Eur Heart J. 2010 Jul;31(14):1802-9
20530501
Eur J Epidemiol. 2001;17(6):521-6
11949723
Blood Press. 2011 Aug;20(4):232-8
21449704
Metabolism. 2009 Aug;58(8):1102-8
19481771
PLoS One. 2013 Jul 12;8(7):e69298
23874938
J Hypertens. 2014 May;32(5):998-1003; discussion 1004
24569414
Obesity (Silver Spring). 2006 Nov;14(11):2089-98
17135627
Menopause. 2008 May-Jun;15(3):524-9
18467953
Ann Med. 2006;38(1):34-41
16448987
PLoS One. 2013 Aug 12;8(8):e70893
23951031
Diabetes Care. 2011 Apr;34(4):1032-7
21330644